Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Asian men more vulnerable to AMD says new study

This article was originally published in Clinica

Executive Summary

Overturning previous assumptions, a new study has found higher prevalence of age-related macular degeneration (AMD) among Asian than among Caucasian men. And a causal link is made to smoking, according to Businesswire.com. The study compared prevalence in 4,000 men from Funagata in Japan to Caucasian participants in the Australian Blue Mountains Eye Study. Although the latest study's authors say confirmation through more extensive analysis is needed, they also suggest a link between smoking and AMD since prevalence among Asian women was significantly lower (than among Asian men) only 2.8% of whom were smokers compared to 14.4% of Caucasian women, who presented a higher rate of AMD compared to their male counterparts. The findings were published in the August issue of the American Academy of Ophthalmology's journal Ophthalmology.

You may also be interested in...



Asia Regulatory Forum Update

Three upcoming medical device regulations were discussed at BSI’s Hong Kong Forum in April that will be important to the success of Hong Kong’s voluntary regulatory system, the Medical Device Administrative Control System.

Saudi Arabia adopts interim device authorisation regulation

Saudi Arabia has adopted an interim marketing authorisation regulation under which, possibly as early as 2010, only medical devices that have been approved by the Saudi Arabia Food and Drug Administration will be allowed on the market1. Additionally, only medical devices that comply with the regulations in force in the European Union, the US, Canada, Japan or Australia – ie in the jurisdiction of a Global Harmonization Task Force founding member - will be eligible for marketing in the country2,3.

Canada takes action to increase more adverse event reporting

The government of Canada has launched a marketing campaign to encourage consumers and healthcare professionals to use the country’s MedEffect initiative for reporting suspected adverse events related to healthcare products1.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT043157

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel